icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Influence of Hepatitis C Virus (HCV) Genotype-1 (G1) Subtype, Baseline Viral Load and IL28B Genotype on Peginterferon (PEG-IFN)/Ribavirin (RBV) Treatment Response: Results of the IDEAL Study
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011 SF
 
A. Rabiee1, H. Tillmann2, F. Poordad3, E.J. Lawitz4, M.L. Shiffman5, A.J. Muir2, S. Noviello6, C.A. Brass6, L.D. Pedicone6, J.K. Albrecht6, M.S. Sulkowski1, I. Jacobson7
1Johns Hopkins University, Baltimore, MD, U.S.A.; 2Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, U.S.A.; 3Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.; 4Alamo Medical Research, San Antonio, TX, U.S.A.; 5Liver Institute of Virginia, Bon Secours Health System, Richmond and Newport News, VA, U.S.A.; 6Merck, Sharp, & Dohme, Corp., Whitehouse Station, NJ, U.S.A.; 7Weill Cornell Medical College, New York, NY, U.S.A.

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif